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Green chemical approach has been developed by using ionic liquid [MIM-H] CCl3 and TiO2 nanoparticles (NPs) for the 
synthesis of 3,4-dihydropyrimidine-2(1H)-one (DHPMs) derivatives 4a-r. The formed compounds have been characterised 
by IR, 1H and 13C NMR and mass spectrometry. 
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Biginelli reaction is well established reaction for the 
synthesis of heterocyclic compounds in synthetic 
organic chemistry for last few years
1-3
. This reaction 
is continuously in research attention due to significant 
role of 3,4-dihydropyrimidine-2(1H)-one (DHPMs) 
compound as therapeutic agents. The compound 
DHPM is nitrogen containing heterocycle and is very 
important in the field of medicinal chemistry, it has 
wide range of biological
4,5
 activities such as 
antibacterial
6
, antihypertensive activity
7,8
, antifungal
9
, 
antiviral
10
, anticancer
11
, antidiabetic
12
 and many other 
biological properties. A three component reaction of 
aromatic aldehyde, urea and β-ketoester occur and 
produce 3,4-dihydropyrimidine-2(1H)-one (DHPMs) 
by different methods
13-19
. 
Many methods have been reported for the 
preparation of DHPM derivatives and Pietro Biginelli 
in 1893 was the first researcher who has synthesized 
this compound in a single step. To obtain the 
compound 3,4-dihydropyrimidine-2(1H)-one (DHPMs) 
the reaction was carried out simply by heating the 
mixture of three components in ethanol with catalytic 
amount of HCl but this provides only low to moderate 
yield of desired product. Feng Xu and co-workers
20
 
(2008) have synthesized the DHPM compound by 
aromatic aldehyde, β-ketoester and urea in presence 
of CuCl2.5H2O, Luciana M. Ramos and co-workers
21
 
(2012) synthesized the compound by using aldehyde, 
urea and 1,3-diketone in presence of strong lewis  
acid catalyst, Min Wang and coworkers
22
 (2014) 
synthesized DHPM compound by using aromatic 
aldehyde, aromatic ketone and urea in presence of 
catalyst [SnCl4.5H2O] and many other methods were 
reported, but these methods had many drawbacks 
such as use of organic solvent, high reaction time, low 
product yield, expensive reaction work up and use of 
harmful chemicals which are responsible for the 
environmental pollution. 
In short most of above reported methods includes 
harsh reaction conditions for the synthesis of 3,4-
dihydropyrimidine-2(1H)-one (DHPMs) derivatives 
through Biginelli type reactions but recently, the 
environment friendly techniques have also been 
developed in synthetic organic chemistry such as 
green chemistry. The replacement of organic solvent 
by the green solvent has been increased in synthetic 
organic chemistry in the most of the industrial field 
because of its green characteristics like non-
flammability, high thermal stability, high chemical 
stability, low vapor pressure and recycling of ionic 
liquid
23-26
. The advantages of ionic liquid has been 
confirmed by enhancing reactivity and selectivity in 
many examples therefore the use of the green solvent 
is the demand of today's chemistry
27
. 
Many researchers had synthesized the useful 
products by this reaction in good quantity but the 
generation of waste by products was neglected which 
was responsible for environmental pollution, therefore 
to minimize the waste and keep the environment 
healthy various methods have been developed and one 
of them is the use of TiO2 (NPs) as a heterogeneous 
catalyst. In the present article we have used TiO2 NPs 
as a heterogeneous catalyst because it provides large 
surface area to adsorbed the reactant which leads to 
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the fast reaction rates and it has high stability, low 
cost and safety towards human as well as 
environment. 
We have synthesized compounds with better yield 
in shorter time by using ionic liquid {[MIM-H] CCl3} 
as a green solvent in place of organic solvent  
and TiO2 as a heterogeneous catalyst. The compound 
3,4-dihydropyrimidine-2(1H)-one (DHPMs) was 
synthesized by a one pot process which involves the 
following reaction (Scheme I). 
The ionic liquid used in the reaction 1-methyl- 3-
hydro-1H-imidazol-3-ium trichloromethanide {[MIM-
H] CCl3} was synthesized by following reaction 
(Scheme II). 
 
Results and Discussion 
We have synthesized eighteen different DHPM 
derivatives and their structures were confirmed by 
spectral analysis. The carbonyl group of NH-CO 
(amide) was observed at 1670-1700 cm
−1
, CO bond of 
ketonic group in β-ketoester observed at 1730-1750 
cm
−1
 and C=C stretching peak of aromatic ring 
observed at 1620-1650 cm
−1
. Appearence of NH 
streaching peak at cm
−1
 confirmed the formation of 
ionic liquid appears. In 
1
H NMR spectra amide proton 
observed at 5-8 ppm. The proton attached to 
methylene (-CH2) was observed at 4-6 ppm. The 
proton of phenyl ring were observed at 6-7.3 ppm. 
The proton of (-CH3) group attached to oxygen of 
ether (4d, 4j, 4p) was observed at 3.5-4.0 ppm. In 
ionic liquid CH3 proton appear at 3.56 ppm. In mass 
spectra the molecular ion peaks were observed 
according to their molecular weight. 
As shown in Table I, the best results were obtained 
when the reaction was occurred in 1.0 mL of {[MIM-
H] CCl3 as a green solvent and TiO2 (1 mol%) as a 
catalyst at RT. Whereas product yield was not 
obtained in absence of catalyst even after 1 hour at 
RT and 100ºC. 
 
Effect of polarity of organic solvent v/s green 
solvent on the reaction 
Reaction of aromatic aldehyde, urea and β-
ketoester, in presence of different solvent like H2O, 
C2H5OH, CH3CN, CH2Cl2, etc. has been observed at 
RT, but in presence of green solvent better yield was 
obtained as compared to organic solvent (Table II and 
Table III). 
As Biginelli reaction is three component reaction, 
aromatic aldehyde, β-ketoester and urea, this reaction 
is expected to proceed in following manner, 
 
 
Scheme I — Biginelli type reaction 
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Scheme II — Preparation of Ionic liquids 
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nucleophilic attack of urea at carbonyl carbon of 
aromatic aldehyde to yield iminium ion as an 
intermediate and this iminium ion further reacted with 
β-ketoester and finally it gave DHPM compound by 
the removal of water (Scheme III). 
 
Reusability of {[MIM-H] CCl3} ionic liquid  
At the end of the reaction, ethyl acetate was added 
to the reaction mixture to separate the reactant  
and product. The reaction mixture was washed with 
water to separate product and catalyst (the product is 
soluble in ethyl acetate and catalyst is soluble in 
water). Layer was formed between water and product, 
water containing ionic liquid was separated from the 
product and it was again reused for other reaction 
after removing water. 
 
Experimental Section 
The chemicals for synthesis were purchased from 
Alfa Asear and Sigma Aldrich and used without 
further purification. The homogeneity of synthesized 
compound was monitored by thin layer chromatography 
(TLC) and visualized by UV chamber. The IR spectra 
were recorded in KBr on Shimadzu 8400S FTIR 
spectrophotometer in cm
−1
. The 
1
H and 
13
C NMR 
were recorded on Jeol resonance spectrometer in 
CDCl3/DMSO-d6 using TMS as an internal standard 
at 300 MHz and 100 MHz. Chemical shifts were 
measured in δ (ppm). Mass spectra were recorded on 
Jeol SX 102/DA 600 using Argon/Xenon gas. 
General process for the synthesis of ionic liquid: 1-
methyl-3-hydro-1H- imidazole-3-ium trichloromethanide 
{[MIM-H] CCl3} 
Round bottom flask of 50 mL having 1-
methylimidazole (3 mmol) have been taken, CH3CN 
(5 mL), chloroform (3 mmol) were added to the 
reaction mixture and stirred it at RT for 30 min. After 
completion of the reaction solvent was removed by 
distillation, the product was dried at 80-100ºC for 120 
min (Scheme II). 
 
General method for the synthesis of 3,4-
dihydropyrimidin-2(1H)-one (DHPM) derivatives 
A mixture of aromatic aldehyde 1 (1 mmol), β-
ketoester 3 (1 mmol) and urea 2 (1 mmol) was taken 
in round bottom flask,TiO2 NPs (1 mol%) as a 
catalyst and 1-methyl-3-hydro-1H-imidazol-3-ium 
trichloromethanide {[MIM-H] CCl3} ionic liquid  
(1.0 mL) as a green solvent were added in the  
reaction mixture, the reaction mixture was 
magnetically stirred at RT. The progress of reaction 
was monitored by TLC as a disappearance of 
reactants, after completion of procedure ethyl acetate 
(10 mL) was added to the reaction mixture and 
refluxed for next 10 min, and then washed with water 
(10 mL), finally the reaction mixture was 
recrystallized from ethanol. In this work, ionic liquid 
was recycled and reused without loss of its catalytic 
activity. 
Table I — Effect of amount of catalyst and temperature on the reaction conditions for compound (4d) 
S.No. Amount of TiO2 NPs (mol%) Temperature (°C) Time (min) Yield (%) 
1 0.1 RT 80 − 
2 0.1 100°C 80 − 
3 0.2 RT 80 − 
4 0.2 100°C 80 − 
5 0.3 RT 60 − 
6 0.3 100°C 60 − 
7 0.5 RT 40 59 
8 0.5 100°C 40 59 
9 1 RT 5 94 
10 1 100°C 5 94 
11 2 100°C 5 94 
12 5 100°C 5 94 
 
Table II — Effect of solvent on reaction conditions 
S.No. Solvent Time (min) Yield (%) 
1 CH2Cl2 30 77 
2 CH3CN 15 90 
3 C2H5OH 10 94 
4 H2O 10 94 
5 Ionic liquid 5 94 
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Table III — Structures of compounds with their yield 
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Methyl 1,2,3,4-tetrahydro-6-methyl-2-oxo-4-
phenylpyrimidine-5-carboxylate, 4a: Brown solid. 
IR (KBr): 3320 and 3315 (NH str.), 1727 (COOR), 
1694 and 1663 cm
−1
 (C=O str.); 
1
H NMR (300 MHz, 
DMSO-d6): δ 9.5 (s, 1H, NH-3), 7.85 (s, 1H, NH-1), 
7.22-7.43 (m, 5H, Ar-H) 5.22 (s, 1H, CH), 2.58 (s, 
3H, OCH3), 2.33 (s, 3H, CH3); 
13
C NMR (100 MHz, 
CD3COCD3): δ 164, 156, 137.5, 128, 108, 50.2, 42.8, 
17.5. Anal. Calcd for C13H14N2O3: C, 69.48; H, 6.61; 
N, 5.4. Found: C, 68.97; H, 6.21; N, 5.78%. 
Ethyl 1,2,3,4-tetrahydro-6-methyl-2-oxo-4-
phenylpyrimidine-5-carboxylate, 4b: Brown solid. 
IR (KBr): 3320 and 3315 (NH str.), 1725 (COOR), 
1695 and 1665 cm
−1
 (C=O str.); 
1
H NMR (300 MHz, 
DMSO-d6): δ 1.04 (t, 3H, OCH2CH3), 2.31 (s, 3H, 
CH3), 3.95 (q, 2H, OCH2CH3), 5.20 (s, 1H, CH),7.21-
7.42 (m, 5H, Ar-H), 7.86 (s, 1H, NH-1) 9.50 (s, 1H, 
NH-3), 3.8 (s, 3H, OCH3); 
13
C NMR (100 MHz, 
CD3COCD3): δ 167, 155, 146.3, 143, 129.2, 
125.5,123, 100.3, 60,54.4, 17.8, 14. Anal. Calcd for 
C14H16N2O3: C, 74.68; H, 7.44; N, 5.44. Found: C, 
74.14; H, 7.12; N, 4.96%. 
Isopropyl 1,2,3,4-tetrahydro-6-methyl-2-oxo-4-
phenylpyrimidine-carboxylate, 4c: Brown solid. IR 
(KBr): 3323 and 3313 (NH str.), 1730 (COOR), 1694 
and 1665 (C=O str.), 1440 cm
−1
 (C-C str.); 
1
H NMR 
(300 MHz, DMSO-d6): δ 9.5 (s, 1H, NH-3), 7.86 (s, 
1H, NH-1), 7.21-7.44 (m, 5H, Ar- H), 5.21 (s, 1H, 
 
 
Scheme III — Proposed mechanism for the synthesis 
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CH), 4.15 (m, 1H, -CH-), 2.34 (s, 3H, CH3), 1.34  
(d, 6H, CH3); 
13
C NMR (100 MHz, CD3COCD3): δ 
165, 157.3, 139.2, 128.6, 106.4,68.8, 43,22, 17.45. 
Anal. Calcd for C15H18N2O3: C, 75.25; H, 7.80; N, 
5.16. Found: C, 75.84; H,7.12; N, 4.96%. 
2-Methoxy ethyl 1,2,3,4-tetrahydro-6-methyl-2-
oxo-4-phenylpyrimidine-5-carboxylate, 4d: Brown 
solid. IR (KBr): 3440 (NH), 1750 (COOR), 1685 cm
−1
 
(CONH); 
1
H NMR (300 MHz, DMSO-d6): δ 7.4-
7.15 (m, 5H, Ar-H), 6.16 (s, 2H,NH), 4.32 (t, 2H, -
CH2-), 3.6 (t, 2H, -CH2-) 3.2 (s, 3H, CH3) 1.7 (s, 3H, 
CH3); 
13
C NMR (100 MHz, CD3COCD3): δ 165.2, 
156.6, 140, 128.2, 105.8, 72, 67.2, 54,42.6, 17.3. 
Anal. Calcd for C15H18N2O4: C, 71.06; H, 7.37; N, 
4.87. Found: C, 70.45; H,7.68; N, 4.13%. 
Methyl 1,2,3,4-tetrahydro-6-ethyl-2-oxo-4-
phenylpyrimidine-5-carboxylate, 4e: Brown solid. 
IR (KBr): 3450 (NH), 1745 (COOR), 1680 (CONH), 
1445 cm
−1
 (C-C str.); 
1
H NMR (300 MHz, DMSO-
d6): δ 7.54-7.12 (m, 5H, Ar-H), 6.18 (s, 2H, NH), 3.8 
(s, 3H, -CH3), 2.1 (m, 2H,- CH2-)1.04 (t, 3H, CH3); 
13
C NMR (100 MHz, CD3COCD3): δ 165.7, 156.3, 
142, 127.5, 107.2, 52, 43, 30,9. Anal. Calcd for 
C14H16N2O3: C, 74.68; H, 7.44; N, 5.44. Found: C, 
73.79; H, 7.03; N, 5.15%. 
Ethyl 1,2,3,4-tetrahydro-2-oxo-4-phenyl-6-
propyl-pyrimidine-5-carboxylate, 4f: Brown solid. 
IR (KBr): 3455 (NH), 1755 (COOR), 1685 (CONH), 
1450 cm
−1
 (C-C str.); 
1
H NMR (300 MHz, DMSO-
d6): δ 7.47-7.08 (m, 5H, Ar-H), 6.13 (d, 2H, NH), 4.1 
(Q, 2H, -CH2-), 1.9 (t, 2H,- CH2-)1.34 (m, 3H, - CH2-), 
1.24 (t,3H, CH3), 1.0 (t, 3H, CH3); 
13
C NMR  
(100 MHz, CD3COCD3): δ 163.9, 155, 144.5,105.4, 
60, 42.9, 34.3, 17.4, 14, 13.5. Anal. Calcd for 
C16H19N2O3: C, 75.76; H, 8.12; N, 4.91. Found: C, 
75.13; H, 7.82; N, 5.10%. 
Methyl 1,2,3,4-tetrahydro-6-methyl-2-oxo-4-
styryl-pyrimidine-5-carboxylate, 4g: Brown solid. 
IR (KBr): 3445 (NH), 1750 (COOR), 1680 cm
−1
 
(CONH); 
1
H NMR (300 MHz, DMSO-d6): δ 7.52- 
7.02 (m, 5H, Ar-H), 6.13 (d, 2H, NH), 5.8 (d,  
1H, -CH-), 3.72 (s, 3H,- CH3-) 1.7 (s, 3H,- CH3-); 
13
C NMR (100 MHz, CD3COCD3): δ 164.8, 156.7, 
137.5, 126.4, 124.2, 108, 50.7, 49, 17.2. Anal. Calcd 
for C15H16N2O3: C, 75.81; H, 7.11; N, 5.20. Found: C, 
75.12; H, 6.97; N, 5,56%. 
Ethyl 1,2,3,4-tetrahydro-6-methyl-2-oxo-4-
styryl-pyrimidine-5-carboxylate, 4h: Brown solid. 
IR (KBr): 3460 (NH), 1755 (COOR), 1690 cm
−1
 
(CONH); 
1
H NMR (300 MHz, DMSO-d6): δ  
7.49-7.10 (m, 5H, Ar-H), 6.10 (d, 2H, NH), 5.87  
(d, 1H, -CH-), 4.0 (Q, 2H,- CH2-)1.69 (s, 3H,- CH3-), 
1.3 (t, 3H, CH3); 
13
C NMR (100 MHz, CD3COCD3): 
δ 165.1, 156.9, 139.5, 126.8, 124.3, 106.3, 59.7, 49. 2, 
17, 13.8. Anal. Calcd for C16H18N2O3: C, 72.22; H, 
7.07; N, 4.68. Found: C, 73.11; H, 7.34; N, 5.13%. 
Isopropyl 1,2,3,4-tetrahydro-6-methyl-2-oxo-4-
styryl-pyrimidine-5-carboxylate, 4i: Brown solid. 
IR (KBr): 3465 (NH), 1740 (COOR), 1700 cm
−1
 
(CONH); 
1
H NMR (300 MHz, DMSO-d6): δ  
7.50- 7.12 (m, 5H, Ar-H), 6.0 (d, 2H, NH), 5.89  
(d, 1H, -CH-), 4.3 (m, 1H,- CH-) 1.72 (s, 3H,- CH3-), 
1.34 (d, 6H, CH3); 
13
C NMR (100 MHz, CD3COCD3) 
165.3, 157, 139.2, 126.5,124.1,106.5, 69.1, 49. 0, 22, 
17.2. Anal. Calcd for C17H19N2O3: C, 72.82; H, 7.40; 
N, 4.47. Found: C, 72.23; H, 7.16; N, 4.14%. 
2-Methoxy ethyl 1,2,3,4-tetrahydro-6-methyl-2-
oxo-4-styryl-pyrimidine-5-carboxylate, 4j: Brown 
solid. IR (KBr): 3435 (NH), 1740 (COOR), 1695 cm
−1
 
(CONH); 
1
H NMR (300 MHz, DMSO-d6): δ 7.5- 
7.06 (m, 5H, Ar-H), 5.89 (d, 2H, NH), 5.92 (d, 1H, -
CH-), 4.32 (t, 2H,- CH2-) 3.63 (t, 2H,- CH2-), 3.22  
(s, 3H, CH3) 1.71 (s, 3H,- CH3-); 
13
C NMR  
(100 MHz, CD3COCD3): δ 165, 156.6, 139.2, 126.9, 
124.1, 106.2, 72, 67.7, 53.7 49. 1, 17.3. Anal. Calcd 
for C17H20N2O4: C, 76.72; H, 7.80; N, 4.71. Found: C, 
76.24; H, 7.28; N, 4.37%. 
Methyl 1,2,3,4-tetrahydro-6-methyl-2-oxo-4-
styryl-pyrimidine-5-carboxylate, 4k: Brown solid. 
IR (KBr): 3445 (NH), 1750 (COOR), 1705 cm
−1
 
(CONH); 
1
H NMR (300 MHz, DMSO-d6): δ 7.52- 7.03 
(m, 5H, Ar-H), 6.01(d, 2H, NH), 5.92 (d, 1H, -CH-), 
3.76 (s, 3H, CH3), 2.1 (Q, 2H, - CH2-), 1.03  
(t, 3H,CH3); 
13
C NMR (100 MHz, CD3COCD3): δ 
165.3, 156.3, 142.2, 127, 124.2, 107.2, 51,49. 3,25, 9. 
Anal. Calcd for C16H18N2O3: C,76.29; H,7.48; N,4.94. 
Found: C,75.89; H, 7.16; N, 4.24%. 
Ethyl 1,2,3,4-tetrahydro-2-oxo-6-propyl-4-
styryl-pyrimidine-5-carboxylate, 4l: Brown solid. 
IR (KBr): 3465 (NH),1760 (COOR), 1710 cm
−1
 
(CONH); 
1
H NMR (300 MHz, DMSO-d6): δ 7.50- 7.03 
(m, 5H, Ar-H), 6.04(d, 2H, NH), 5.90 (d, 1H, -CH-), 
4.18 (Q, 2H,- CH2-), 1.95 (t, 2H, - CH2-), 1.36  
(Q, 2H,-CH2-), 1.3 (t, 3H, CH3), 0.96 (t, 3H, CH3); 
13
C NMR (100 MHz, CD3COCD3): δ 165.1, 156.3, 
144.6, 127, 124.2, 105.2, 60, 49. 3, 34.5, 17.5, 14, 
13.7. Anal. Calcd for C18H22N2O3: C, 77.14; H, 8.09; 
N, 4.50. Found: C, 76.82; H, 7.89; N, 4.13%. 
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Methyl 1,2,3,4-tetrahydro-6methyl-4-(5-methyl-
furan-2-yl)-2-oxo-pyrimidine-5-carboxylate, 4m: 
Brown solid. IR (KBr): 3470 (NH), 3000 (C-Hstr), 
1750 (COOR), 1700 (CONH), 1650 (C=C), 1150 
cm
−1
 (C-O); 
1
H NMR (300 MHz, DMSO-d6): δ 7.2 
(d, 1H, CH-), 6.15- 1.45 (d, 2H, Ar-H), 6.0  
(d, 2H, NH), 3.78 (s, 3H,CH3) 2.19 (s, 3H, CH3), 
1.69 (s, 3H, CH3); 
13
C NMR (100 MHz, 
CD3COCD3): δ 165, 156.8, 150.6, 137.7, 108.1, 
106.2, 51, 16.7. Anal. Calcd for C12H14N2O4: C, 
68.00; H, 6.93; N,5.66. Found: C, 67.76; H, 6.37; N, 
5.25%. 
Ethyl 1,2,3,4-tetrahydro-6-methyl-4-(5-methyl-
furan-2-yl)-2-oxo-pyrimidine-5- carboxylate, 4n: 
Brown solid. IR (KBr): 3455 (NH), 2970 (C-Hstr), 
1755(COOR), 1695 (CONH), 1620 (C=C), 1170 cm
−1
 
(C-O); 
1
H NMR (300 MHz, DMSO-d6): δ 7.18  
(d, 1H, CH-), 6.17- 1.42 (d, 2H, Ar-H), 6.02 (d, 2H, 
NH), 4.2 (Q, 3H, CH3), 2.2 (s, 3H,CH3) 1.71 
(s,3H,CH3), 1.32 (t,3H,CH3); 
13
C NMR (100 MHz, 
CD3COCD3): δ 165.2, 157, 150.7, 139.5, 106.4, 
60,51, 16.5, 13.8. Anal. Calcd for C13H16N2O4: C, 
68.94; H, 7.33; N,5.36. Found: C, 68.43; H, 7.12; N, 
5.20%. 
Isopropyl 1,2,3,4-tetrahydro-6-methyl-4-(5-
methyl-furan-2-yl)-2-oxo-pyrimidine-5-carboxylate, 
4o: Brown solid. IR (KBr): 3480 (NH), 3050 (C-Hstr), 
1755 (COOR), 1720 (CONH), 1630 (C=C), 1170 cm
−1
 
(C-O); 
1
H NMR (300 MHz, DMSO-d6): δ 7.21 (d, 1H, 
CH-), 6.18- 1.46 (d, 2H, Ar-H), 6.04(d, 2H, NH), 4.32 
(m, 1H, -CH-), 2.17 (s, 3H, CH3) 1.72 (s, 3H, CH3), 1.35 
(d,6H,CH3); 
13
C NMR (100 MHz, CD3COCD3): δ 
165.4, 156.8, 150.9, 138.9, 106.6, 70,51, 22,16.7. Anal. 
Calcd for C14H18N2O4: C, 69.79; H, 7.69; N,5.09. Found: 
C, 69.47; H, 7.27, N, 4.97%. 
2-Methoxy ethyl 1,2,3,4-tetrahydro-6-methyl-4-
(5-methyl-furan-2-yl)-2-oxo-pyrimidine-5-
carboxylate, 4p: Brown solid. IR (KBr): 3490 
(NH),3070 (C-Hstr), 1755 (COOR),1715 (CONH), 
1650 (C=C), 1200 (C-O), 1100 and 1220 cm
−1
 (C-O-
C); 
1
H NMR (300 MHz, DMSO-d6): δ 7.24 (d, 1H, 
CH-), 6.18- 1.46 (d, 2H, Ar-H), 6.0(d, 2H, NH), 4.34 
(t, 2H, -CH2-), 3.67 (t,2H,-CH2-),3.25 (s,3H, CH3), 
2.17 (s,3H,CH3), 1.72 (s, 3H, CH3); 
13
C NMR (100 
MHz,CD3COCD3): δ 165.7, 157.4, 150.7, 139.3, 
106.6, 72.2, 67.4, 53.7, 51, 17.2. Anal. Calcd for 
C14H18N2O5: C, 65.96; H, 7.27; N, 4.81. Found: C, 
65.45; H, 5.57; N, 4.46%. 
Methyl 1,2,3,4-tetrahydro-6-ethyl-4-(5-methyl-
furan-2-yl)-2-oxo-pyrimidine-5-carboxylate, 4q: 
Brown solid. IR (KBr): 3495 (NH), 3090 (C-Hstr), 1755 
(COOR), 1710 (CONH), 1650 (C=C), 1220 (C-O), 1090 
and 1230 cm
−1
 (C-O-C); 
1
H NMR (300 MHz,  
DMSO-d6): δ 7.21 (d, 1H, CH-), 6.15- 1.45 (d, 2H,  
Ar-H), 6.02 (d, 2H, NH), 3.76 (s, 3H, CH3), 2.18  
(s, 3H, CH3) 2.1 (Q, 2H,-CH2-)1.04 (t, 3H, CH3); 
13
C NMR (100 MHz, CD3COCD3): δ 165, 156.8, 150.6, 
142.5, 107.3, 106.2.50.8, 51.3, 24.48.7. Anal. Calcd for 
C13H16N2O4: C, 64.96; H, 6.91; N,5.05. Found: C, 65.10; 
H, 6.28; N, 4.67%. 
Ethyl 1,2,3,4-tetrahydro4-(5-methyl-furan-2-yl)-
2-oxo-6-propyl-pyrimidine-5-carboxylate, 4r: 
Brown solid. IR (KBr): 3470 (NH), 3100 (C-Hstr), 
1750 (COOR), 1700 (CONH), 1650 (C=C), 1200  
(C-O), 1080 and 1250 cm
−1
 (C-O-C); 
1
H NMR (300 
MHz, DMSO-d6): δ 7.2 (d, 1H, CH-), 6.18-1.46  
(d, 2H, Ar-H), 6.01 (d, 2H, NH), 4.2 (q, 2H, -CH2-), 
2.18 (s, 3H, CH3), 2.0 (t, 2H, -CH2-), 1.38 (m, 2H, -
CH2-), 1.3 (t, 3H, CH3), 1.0 (t,3H,CH3); 
13
C NMR 
(100 MHz, CD3COCD3): δ 165.4, 156.8, 150.7, 144.5, 
105.1, 59.8, 51.2, 33.8, 17.5, 14.0, 13.6. Anal. Calcd 
for C15H20N2O4: C, 70.56; H, 8.01; N, 4.85. Found: C, 
70.16; H, 7.65; N, 4.56%. 
 
Conclusion 
A new and simple modified series of 3,4-
dihydropyrimidin-2(1H)-one DHPM compounds has 
been synthesized using green approach. This approach 
employs readily available ionic liquid as a green 
solvent and TiO2 NPs as a catalyst. The yield of the 
products in Biginelli protocol can be increased by  
60-70% as compared to earlier reported methods. 
Therefore, this single step procedure for the synthesis 
of DHPM derivatives is superior in its simplicity and 
higher yields as compared to other alternative 
multistep syntheses that are already reported. 
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